However, in the group treated with LETZ+ GA we observed significant increase ((p < 0.001) in the levels of CYP11a1 and CYP19a1 expression in comparison to LETZ-induced PCOS group (Fig. 7). The gene discussed is CYP11A1; the disease is polycystic ovary syndrome.